Menu
BroadOak is a founding sponsor of BioTools Innovator, the premier accelerator for life sciences research tools companies. Based in Los Angeles, California, BioTools Innovator matches industry leaders with innovative early-stage and emerging growth biotechnology-focused companies for mentorship and support.
Many early-stage companies have an excellent team and ideas, but lack the experience needed to execute their vision and the funding to fuel growth. BroadOak, and others, provide mentorship free-of-charge to BioTools Innovator companies. After several months of working together, this level of focus and support helps set up BioTools Innovator companies for long term success.
BioTools Innovator’s mission is to “improve human health by accelerating the growth of life science tools and diagnostics companies.” The program provides early-stage life sciences companies with educational materials, networking opportunities, exposure to key stakeholders in the life sciences industry, and the opportunity to receive funding and mentorship.
Learn more here if you’re interested in BioTools Innovator.
The third BioTools Innovator cohort included 19 startups selected from an applicant pool of well-over 300 exciting companies.
Limula, a Swiss company providing a modular solution for on-demand and at-scale manufacturing of cell therapies in a single device, was chosen as the winner of BioTools Innovator’s 2023 cash Grand Prize.
Runner-up companies, including Andson Biotech, BioRaptor, and Aopia Biosciences, also received cash prizes.
It was an honor for BroadOak’s BioTools Venture Fund team to support the BioTools Innovator Capstone event. DeciBio Managing Director Carl Schoellhammer participated in a rapid-fire panel highlighting industry trends, while BroadOak Managing Director Austin Duke served as a judge for the finals competition.
Read the full event recap press release.
Click here for more information on how to participate in the 2024 BioTools Innovator cohort.
Accellix is benefiting from the BroadOak team’s deep industry expertise, high engagement, and constant availability to advise us on strategic matters. From a transaction perspective, BroadOak has tailored a structure to meet our needs.
Nir Nimrodi
CEO | Accellix
We invest in and advise life sciences companies with a focus on Cell and Gene Therapy, Single Cell Genomics, and Life Sciences Software.
Stay connected
Partner with BroadOak